VISTA-16 Trial Site
Vascular Inflmation Suppression to Treat Acute Coronary Syndrome for 16 weeks...read more
PEARL-SC Trial SitePhase 2b Study to Evaluate the Efficacy, Safety, & Tolerability of A-623 AdministRation in Subjects with Systemic Lupus Erythematosus...read more
FRANCIS Trial SiteFewer Recurrent Acute coronary events with Near-term Cardiovascular Inflammation Suppression...read more
IMPACTS Trial SiteInvestigation of the Modulation of Phospholipase in Acute ChesT Syndrome...read more
